Tigecycline exhibits inhibitory activity against Clostridium difficile in the intestinal tract of hospitalised patients

International Journal of Antimicrobial Agents

Volumn 45, Issue 4, 2015, Pages 424-426

  Kundrapu, Sirisha ^a   Hurless, Kelly ^a   Sunkesula, Venkata C K ^a   Tomas, Myreen ^a,b   Donskey, Curtis J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Geriatric Research   (United States)

Author keywords

Clostridium difficile; Inhibition; Tigecycline

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; TIGECYCLINE; ANTIINFECTIVE AGENT; MINOCYCLINE;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; FECES ANALYSIS; HOSPITALIZATION; HUMAN; IN VITRO STUDY; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; LIMIT OF DETECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CLOSTRIDIUM INFECTIONS; COHORT ANALYSIS; DRUG EFFECTS; FECES; FEMALE; GASTROINTESTINAL TRACT; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; PROSPECTIVE STUDIES;

EID: 84925510909     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.11.016     Document Type: Article

References (8)

1. C.E. Nord, E. Sillerström, and E. Wahlund Effect of tigecycline on normal oropharyngeal and intestinal microflora Antimicrob Agents Chemother 50 2006 3375 3380
2. S.D. Baines, K. Saxton, J. Freeman, and M.H. Wilcox Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model J Antimicrob Chemother 58 2006 1062 1065
3. M.H. Wilcox Evidence for low risk of Clostridium difficile infection associated with tigecycline Clin Microbiol Infect 13 2007 949 952
4. B.L. Herpers, B. Vlaminckx, O. Burkhardt, H. Blom, H.S. Biemond-Moeniralam, and M. Hornef Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection Clin Infect Dis 48 2009 1732 1735
5. R.C. Owens Jr., C.J. Donskey, R.P. Gaynes, V.G. Loo, and C.A. Muto Antimicrobial-associated risk factors for Clostridium difficile infection Clin Infect Dis 46 2008 19 31
6. M.M. Nerandzic, and C.J. Donskey Effective and reduced-cost modified selective medium for isolation of Clostridium difficile J Clin Microbiol 47 2009 397 400
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20 2010 CLSI Wayne, PA
8. S.P. Borriello, and F.E. Barclay An in-vitro model of colonisation resistance to Clostridium difficile infection J Med Microbiol 21 1986 299 309